EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Characterisation of two highly oncogenic strains of Marek's disease virus


Avian Pathology 11(4): 593-605
Characterisation of two highly oncogenic strains of Marek's disease virus
The RB-1B and ALA-8 strains of Marek's disease (MD) virus, which were isolated from chickens with MD and which had been vaccinated with the herpesvirus of turkeys (HVT), were evaluated for their oncogenic potential in genetically susceptible (P-line) and resistant (N-line, PDRC) chickens. RB-1B and ALA-8 were both highly oncogenic, causing a high prevalence of MD in both susceptible and resistant birds. Vaccination of P-line birds with SB-1 or HVT did not protect satisfactorily against RB-1B.


Accession: 001053136

PMID: 18770225

DOI: 10.1080/03079458208436134



Related references

Difference in the meq gene between oncogenic and attenuated strains of Marek's disease virus serotype 1. Journal of Veterinary Medical Science 62(3): 287-292, 2000

Effects of polychlorinated biphenyls on the infection of chickens with non-oncogenic Marek's disease virus strains. Acta Veterinaria Brno 61(4): 207-217, 1992

Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus. Virus Genes 35(3): 753-766, 2007

Detection of DNA polymorphisms between oncogenic and attenuated serotype 1 Marek's disease virus strains using RAPD markers. Current research on Marek' s disease Proceedings of the 5th International Symposium, East Lansing, Michigan, 7-11 September 1996,: 148-153, 1996

Effect of diluting Marek's disease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's disease viruses. Avian Diseases 55(2): 263-272, 2011

Differentiation of oncogenic and nononcogenic strains of Marek's disease virus type 1 by using polymerase chain reaction DNA amplification. Avian Diseases 36(3): 637-645, 1992

Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek's disease virus. Journal of General Virology 88(Pt 4): 1080-1096, 2007

A 14-kDa immediate-early phosphoprotein is specifically expressed in cells infected with oncogenic Marek's disease virus strains and their attenuated derivatives. Virology New York 206(1): 695-700, 1995

A 14-kDa immediate-early phosphoprotein is specifically expressed in cells infected with oncogenic Marek's disease virus strains and their attenuated derivatives. Virology 206(1): 695-700, 1995

In vitro cytotoxicity of spleen lymphocytes against Marek's disease tumour cells: induction by SB-1, an apparently non-oncogenic Marek's disease virus. Resistance and immunity to Marek' s disease: 301-316, 1980